Arbutus Biopharma (ABUS) FCF Margin Growth (1y) (2014 - 2026)
Arbutus Biopharma (ABUS) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 75,460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,460.00 |
| Dec 31, 2025 | 21,551.00 |
| Sep 30, 2025 | 44,900.00 |
| Jun 30, 2025 | 69,373.00 |
| Mar 31, 2025 | 50,654.00 |
| Dec 31, 2024 | 14,535.00 |
| Sep 30, 2024 | -108,026.00 |
| Jun 30, 2024 | -40,138.00 |
| Mar 31, 2024 | -85,565.00 |
| Dec 31, 2023 | -53,195.00 |
| Sep 30, 2023 | -15,278.00 |
| Jun 30, 2023 | -29,502.00 |
| Mar 31, 2023 | -57,331.00 |
| Dec 31, 2022 | 33,915.00 |
| Sep 30, 2022 | 16,514.00 |
| Jun 30, 2022 | 48,465.00 |
| Mar 31, 2022 | 101,422.00 |
| Dec 31, 2021 | 2,223.00 |
| Sep 30, 2021 | 31,935.00 |
| Jun 30, 2021 | -4,297.00 |